Avoidance of invasive diagnostic and harmful therapeutic measures in a patient with malignant fibrous histiocytoma and extensive clinically occult metastases

Journal of the National Medical Association

Volumn 101, Issue 9, 2009, Pages 953-955

  Bucerius, Jan ^a   Buchholz, Bettina ^a   Strunk, Holger ^a   Palmedo, Holger ^a   Biersack, Hans Jürgen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Tumor

Indexed keywords

DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; IFOSFAMIDE;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; HISTOGENESIS; HUMAN; INVASIVE PROCEDURE; LUNG METASTASIS; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; METASTASIS; OCCULT CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RARE DISEASE;

EID: 70350076999     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)31044-0     Document Type: Article

References (6)

1. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the PET literature. J Nucl Med. 2001;42:1S-93S.
2. Reske SN, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. Eur J Nucl Med. 2001;28:1707-1723.
3. Kobayashi E, Kawai A, Seki K, Tateishi U, Beppu Y. Bilateral adrenal gland metastasis from malignant fibrous histiocytoma: Value of [F-18]FDG PET-CT for diagnosis of occult metastases. Ann Nucl Med. 2006;10:695-698.
4. Stadler FJ, Scott GA, Brown MD. Malignant fibrous tumors. Semin Cutan Med Surg. 1998;17:141-152.
5. Anagnostopoulos G, Sakorafas GH, Grigoriadis K, Kostopoulos P. Malignant fibrous histiocytoma of the liver: A case report and review of the literature. Mt Sinai J Med. 2005;72:50-52. (Pubitemid 40268059)
6. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer. 1978;41:2250-2266. (Pubitemid 8370196)